July 15, 2025 — Vivalink, a provider of digital healthcare solutions, has announced its wearable ECG monitor is supporting research at Brigham and Women’s Hospital in Boston aimed at understanding and improving detection of postoperative atrial fibrillation (poAF).

July 14, 2025  –  Johnson & Johnson MedTech has announced U.S. Food and Drug Administration (FDA) approval of an update to the Varipulse Platform’s irrigation flow rate, reflecting the company’s commitment to the evolution of pulsed field ablation (PFA) innovation following real-world clinical practice. 

July 14, 2025 — Bayer has announced that the U.S. Food and Drug Administration (FDA) approved KERENDIA (finerenone) to treat patients with heart failure (HF) with left ventricular ejection fraction (LVEF) ≥40%,1 following the agency’s Priority Review of its supplemental New Drug Application (sNDA).

July 10, 2025 — On July 2, 2025, Centers for Medicare & Medicaid Services (CMS) issued a National Coverage Determination (NCD) that covers Abbott's FDA approved Transcatheter Edge-to-Edge Repair for Tricuspid Valve Regurgitation (T-TEER) for the treatment of symptomatic tricuspid regurgitation (TR) under Coverage with Evidence Development (CED), when furnished in accordance with the coverage criteria specified in the NCD.

July 1, 2025 — Stereotaxis, a provider of surgical robotics for minimally invasive endovascular intervention, has announced the publication of initial clinical results using the MAGiC catheter in the Journal of Interventional Cardiac Electrophysiology. Titled “First In‑Human Results of the MAGiC Robotic Magnetic Navigation Radiofrequency Ablation Catheter,” the publication is the first peer-reviewed literature supporting the efficacy and safety of Stereotaxis’ MAGiC catheter.

July 10, 2025 — A study led by scientists at King's College London has revealed how the physical orientation of the heart inside the chest dramatically influences the electrical signals captured in an electrocardiogram (ECG) — a discovery that could pave the way for more personalized and accurate heart diagnostics. 

July 7, 2025 — Catheter ablation is a minimally invasive treatment for abnormal heart rhythms. It is often successful in treating various forms of heart rhythm disturbances, including atrial fibrillation (A-fib), but the procedure is associated with visual auras of flashes, flickering lights, or blind spots, similar to the ones seen by people who experience migraine headaches.

July 9, 2025 —  InspireMD, Inc., developer of the CGuard Prime carotid stent system for the prevention of stroke, announced the official commercial launch of the CGuard Prime carotid stent system in the U.S., following its premarket application (PMA) approval from the U.S. Food and Drug Administration (FDA).

June 30, 2025 — A new ESC Clinical Consensus Statement published in the European Heart Journal discusses the key role of vaccination in preventing cardiovascular events following various viral and bacterial infections.1

June 30, 2025 — Heartflow, Inc., a provider of AI technology for coronary artery disease (CAD), will present new data and technology for its AI-enabled Plaque Analysis at the Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting, including final primary endpoint data from the DECIDE Registry. The SCCT Annual Scientific Meeting is taking place July 17-20, 2025 in Montreal.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now